Suchergebnisse - "Gunst, Jesper D"

PubPharm (24)

1

Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets

enthalten in: EBioMedicine | 2023

von Konrad, C. | Iversen, E. | Gunst, J. | +7

2

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence : the randomized phase 2a TITAN trial

enthalten in: Nature medicine | 2023

von Gunst, J. | Højen, J. | Pahus, M. | +30

3

Immunomodulation with IL-7 and IL-15 in HIV-1 infection

enthalten in: Journal of virus eradication | 2023

von Gunst, J. | Goonetilleke, N. | Rasmussen, T. | +1

4

Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1

enthalten in: iScience | 2023

von Cham, L. | Gunst, J. | Schleimann, M. | +9

5

Characteristics of a Danish Post-COVID Cohort Referred for Examination due to Persistent Symptoms Six Months after Mild Acute COVID-19

enthalten in: Journal of clinical medicine | 2022

von Agergaard, J. | Ullahammer, W. | Gunst, J. | +2

6

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial

enthalten in: Nature medicine | 2022

von Gunst, J. | Pahus, M. | Rosás-Umbert, M. | +30

7

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

enthalten in: Nature communications | 2022

von Rosás-Umbert, M. | Gunst, J. | Pahus, M. | +19

8

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection

enthalten in: The EMBO journal | 2022

von van der Sluis, R. | Cham, L. | Gris-Oliver, A. | +23

9

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP) : a randomised, open-label, phase 2A trial

enthalten in: The Lancet. Microbe | 2022

von Gruell, H. | Gunst, J. | Cohen, Y. | +22

10

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection

enthalten in: The EMBO Journal | 2022

von Sluis, R. | Cham, L. | Gris‐Oliver, A. | +23